全球生物材料市场 – 行业趋势及 2031 年预测

生物材料市场分析及规模

在药物输送领域，生物材料是纳米颗粒、微球和水凝胶等创新系统的支柱。这些平台封装治疗剂，防止其降解，并能够精确输送到体内的目标部位。纳米颗粒通常为纳米级，可增强细胞吸收并延长循环时间。微球提供受控释放动力学，确保在较长时间内维持治疗水平。水凝胶具有可调特性，可在空间和时间上控制药物释放，满足特定的生理条件。

2023 年全球生物材料市场规模价值为 1767.3 亿美元，预计到 2031 年将达到 5034.2 亿美元，2024 年至 2031 年预测期内的复合年增长率为 13.98%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

Market Definition

Biomaterials are substances engineered to interact with biological systems for medical purposes, ranging from implants and prosthetics to drug delivery systems. They are designed to be compatible with living tissues, promoting healing and regeneration while often possessing specific mechanical, chemical, and biological properties. Biomaterials play a crucial role in various medical applications, facilitating advancements in healthcare and improving patient outcomes.

Hair Transplant Market Dynamics

Drivers                                                                                          

• Growing Technological Advancements

Breakthroughs in material science, nanotechnology, and biotechnology continually enhance the properties and functionalities of biomaterials, unlocking new applications and improving existing ones. These advancements enable the development of biomaterials with tailored properties such as biocompatibility, mechanical strength, and controlled degradation, meeting the diverse needs of medical, pharmaceutical, and other industries. Advancements in manufacturing processes, such as additive manufacturing and biofabrication, enable the production of complex biomaterial structures with precise control at the micro and nanoscale, driving the market forward.

• Rising Elderly Population

The growing aging population is more prone to age-related health issues such as osteoarthritis, cardiovascular diseases, and dental problems, necessitating the use of biomaterials in medical implants, prosthetics, and tissue engineering solutions. Biomaterials play a crucial role in restoring function and quality of life for elderly individuals by providing durable and biocompatible replacements for degenerated tissues and organs. The demand for biomaterials is amplified by the desire for active and independent lifestyles among the elderly, driving innovation in materials science and biomedical engineering to meet the unique needs of this demographic.

Opportunities

• Increasing Supportive Government Policies

Policies such as research grants, tax incentives, and regulatory frameworks aimed at promoting innovation in healthcare and biotechnology stimulate investment in biomaterials research and development. Additionally, government initiatives focused on healthcare infrastructure development and public health programs create demand for advanced biomaterials used in medical devices, implants, and regenerative medicine. Supportive policies accelerate the translation of biomaterials research into tangible products and therapies by fostering collaboration between academia, industry, and regulatory bodies that ultimately drives market expansion and improving patient outcomes.

• Increasing Demand for Minimally Invasive Procedures

Patients seek less invasive treatment options through which there's a growing need for biomaterials that enable the development of advanced medical devices and surgical techniques. Biomaterials play a pivotal role in these procedures by providing materials for implants, instruments, and surgical tools that are compatible with the body and promote healing. Moreover, biomaterials facilitate the creation of specialized coatings and drug delivery systems used in minimally invasive interventions, enhancing their efficacy and safety. This trend towards minimally invasive procedures drives innovation in biomaterials, spurring research and development efforts to meet the evolving needs of patients and healthcare providers.

Restraints/Challenges

• High Development Costs

The research and development process for biomaterials involves substantial investment in specialized equipment, materials, and skilled personnel. In addition, conducting preclinical and clinical trials to ensure safety and efficacy further adds to the expense. These high costs can deter smaller companies and startups from entering the market, limiting competition and innovation. Moreover, the lengthy development timeline coupled with uncertain regulatory pathways can prolong the time to market, increasing overall expenses and hindering profitability.

• Growing Competition from Alternative Therapies

Traditional treatment modalities such as pharmaceuticals, surgeries, and non-invasive procedures offer established alternatives to biomaterial-based interventions. Patients or healthcare providers may prefer these alternatives due to factors such as familiarity, perceived efficacy, or cost-effectiveness. Biomaterials face stiff competition in the healthcare landscape, requiring continuous innovation and differentiation to maintain market relevance and capture market share.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2023, Evonik launched VESTAKEEP iC4612 3DF and iC4620 3DF, pioneering carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants. These filaments offer a unique combination of strength, ductility, and adaptability, marking a significant leap in personalized medical treatments and underlining Evonik's dedication to innovation in patient care
• In April 2023, Novo Nordisk forged a strategic collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics targeting obesity and diabetes. This collaboration leverages Aspect Biosystems' expertise in bioprinting biomaterials, aligning with Novo Nordisk's commitment to advancing cutting-edge treatments for metabolic disorders
• In March 2023, Invibio Biomaterial Solutions launched Peek-Optima Am filament, a polyetheretherketone polymer-based material designed for the 3D printing of medical devices. This launch expands Invibio's portfolio of innovative biomaterials, offering enhanced manufacturing capabilities for medical applications and reinforcing its position as a leader in the biomaterials industry
• In January 2023, Zimmer Biomet Holdings, Inc. announced its acquisition plans for Embody, Inc., with an initial investment of USD 155 million, potentially increasing to USD 275 million based on future milestones. This strategic move aims to bolster Zimmer Biomet's sports medicine portfolio, particularly focusing on advanced soft tissue healing solutions, reflecting the company's commitment to expanding its product offerings through strategic acquisitions

Biomaterials Market Scope

The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Metallic Biomaterials
  • Stainless Steel
  • Titanium and Titanium Alloys
  • Cobalt-Chrome Alloys
  • Gold
  • Silver
  • Magnesium
• Polymeric Biomaterials
  • Polymethylmethacrylate
  • Polyethylene
  • Polyester
  • Polyvinylchloride
  • Silicone Rubber
  • Nylon
  • Polyetheretherketone
  • Other Polymeric Biomaterials
• Ceramics
  • Calcium Phosphate
  • Zirconia
  • Aluminum Oxide
  • Calcium Sulfate
  • Carbon
  • Glass
• Natural Biomaterials
  • Hyaluronic Acid
  • Collagen
  • 明胶
  • 纤维蛋白
  • 纤维素
  • 几丁质
  • 藻酸盐
  • 丝绸

应用

• 心血管
  • 导管
  • 支架
  • 植入式心脏除颤器
  • 起搏器
  • 传感器
  • 心脏瓣膜
  • 血管移植
  • 导丝
  • 其他的
• 骨科
  • 关节置换
  • 膝关节置换
  • 髋关节置换术
  • 肩关节置换术
  • 其他的
• 眼科
  • 隐形眼镜
  • 人工晶状体
  • 眼部组织功能置换
  • 合成角膜
  • 其他的
• 牙科
  • 牙科植入物
  • 牙骨移植和替代物
  • 牙科膜
  • 组织再生
• 整形外科
  • 软组织填充剂
  • 颅面外科
• 伤口愈合
  • 伤口闭合装置
  • 缝合线
  • 史泰博
  • 手术止血钳
  • 内部组织密封剂
  • 防粘连屏障
  • 疝气网片
• 组织工程
  • 再生医学支架
  • 生物传感纳米材料
  • 无机纳米粒子的定制
• 神经/中枢神经系统应用
  • 调车系统
  • 皮质神经修复术
  • 用于中枢神经系统修复的水凝胶支架
  • 神经干细胞封装
• 其他应用
  • 药物输送系统
  • 胃肠道应用
  • 减肥手术
  • 泌尿应用

 生物材料市场区域分析/见解

对市场进行了分析，并按国家、类型和应用提供了市场规模见解和趋势，如上所述。

本市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷以及南美洲其他地区。   

北美有望在市场中占据主导地位，这得益于政府支持研发计划的优惠政策以及鼓励创新的严格监管框架。此外，该地区还受益于众多主要市场参与者的存在，形成了强大的合作和投资生态系统。这种有利的环境推动了北美走在生物材料创新的前沿，推动了医疗器械、组织工程和再生医学的发展。

亚太地区预计将实现显著增长，因为当地利益相关者采取了战略举措，以加强其在国内和国际的市场占有率。这些举措包括各种措施，例如投资基础设施、技术进步和建立伙伴关系以提高竞争力。因此，该地区预计将经历强劲的经济扩张，推动各个行业的增长，并巩固其作为市场格局中关键参与者的地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和生物材料市场分析

市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• 强生公司（美国）
• 史赛克。（美国）
• CoorsTek Inc.（美国）
• Zimmer Biomet（美国）
• Corbiollagen Matrix, Inc.（美国）
• CRS Holdings, LLC.（美国）
• 伯克利先进生物材料（美国）
• Covalon Technologies Ltd.（加拿大）
• 美敦力公司 (爱尔兰)
• 巴斯夫公司（德国）
• 赢创工业集团 (德国)
• Invibio Ltd.（英国）

SKU-59542